Jacek Bigda
Impact in
- Physiology top 5%
- Adenosine and Purinergic Signaling
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
Papers in
- Immunology 17
- Immunotherapy and Immune Responses 8
- Immune Cell Function and Interaction 6
- Immune Response and Inflammation 3
-
- Cell death mechanisms and regulation 4
- Co-authors
- Grzegorz Stasiłojć (12 shared papers)Patrycja Koszałka (11 shared papers)A Bomirski (2 shared papers)Andrzej Słomiński (1 shared paper)Ewa Łojkowska (4 shared papers)Anna Kawiak (4 shared papers)Andrzej Myśliwski (14 shared papers)Andrzej C. Składanowski (3 shared papers)
- Journals
- Cellular & Molecular Biology Letters (2 papers)Planta Medica (2 papers)Cytokine (2 papers)Lung Cancer (2 papers)Cancer Letters (1 paper)
- Partner nations
- PolandSri LankaUnited States
In The Last Decade
Jacek Bigda
38 papers receiving 544 citations
Peers
Comparison fields: 5 of 85
- Physiology 94
- Toxicology 68
- Microbiology 34
- Immunology 101
- Oncology 110
Countries citing papers authored by Jacek Bigda
This map shows the geographic impact of Jacek Bigda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacek Bigda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacek Bigda more than expected).
Fields of papers citing papers by Jacek Bigda
This network shows the impact of papers produced by Jacek Bigda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacek Bigda. The network helps show where Jacek Bigda may publish in the future.
Co-authors
The 25 scholars most cited alongside Jacek Bigda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 77 | |
| 2 | 1988 | 72 | |
| 3 | 2012 | 53 | |
| 4 | 2016 | 51 | |
| 5 | 2018 | 36 | |
| 6 | 2011 | 33 | |
| 7 | 2015 | 33 | |
| 8 | 2013 | 31 | |
| 9 | 2010 | 21 | |
| 10 | 1993 | 12 | |
| 11 | In vitro and in vivo analyses of the biological activity of RGD peptides towards Ab Bomirski melanoma. | 2003 | 12 |
| 12 | 2001 | 11 | |
| 13 | 2005 | 10 | |
| 14 | 2013 | 9 | |
| 15 | 2019 | 9 | |
| 16 | Indomethacin inhibits kidney metastasis in bomirski melanoma-bearing hamsters, and modulates natural killer cytotoxic activity of tumor hosts in vivo and in vitro. | 1998 | 9 |
| 17 | 2019 | 7 | |
| 18 | 1993 | 7 | |
| 19 | 1993 | 7 | |
| 20 | Synergistic effect of the angiogenesis inhibitor TNP-470 and tumor necrosis factor (TNF) on Bomirski Ab melanoma in hamsters. | 2001 | 6 |
About Jacek Bigda
Jacek Bigda is a scholar working on Immunology, Molecular Biology, Oncology, Cancer Research and Toxicology, having authored 38 papers that have together received 556 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (8 papers), Immune Cell Function and Interaction (6 papers), Bioactive Compounds and Antitumor Agents (4 papers), Cell death mechanisms and regulation (4 papers), Immune Response and Inflammation (3 papers), Adenosine and Purinergic Signaling (3 papers), CAR-T cell therapy research (3 papers) and Neurological Complications and Syndromes (3 papers). The work is most often cited by research in Physiology (94 citations), Toxicology (68 citations), Microbiology (34 citations), Immunology (101 citations) and Oncology (110 citations). Jacek Bigda has collaborated with scholars based in Poland, Sri Lanka and United States. Frequent co-authors include Grzegorz Stasiłojć, Patrycja Koszałka, A Bomirski, Andrzej Słomiński, Ewa Łojkowska, Anna Kawiak, Andrzej Myśliwski, Andrzej C. Składanowski, Maciej Stobiecki and Anna Gwizdek‐Wiśniewska. Their work appears in journals such as Cellular & Molecular Biology Letters, Planta Medica, Cytokine, Lung Cancer and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.